Have you or your loved ones been diagnosed with advanced solid tumors?

You may be eligible to participate in a advanced solid tumors clinical trial.

Have you or your loved ones been diagnosed with advanced solid tumors? You may be eligible to participate in a advanced solid tumors clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Advanced Solid Tumors Clinical Trial
NCT01946074 | Phase 1 | Interventional
AbbVie
Sponsored by
AbbVie

Have you or your loved ones been diagnosed with advanced solid tumors?

You may be eligible to participate in a advanced solid tumors clinical trial.

Have you or your loved ones been diagnosed with advanced solid tumors? You may be eligible to participate in a advanced solid tumors clinical trial.

Completed

Male & Female

18 - 99

Years old

This study has recruited 101 Participants

This is a Phase 1/1b open-label study evaluating the safety, pharmacokinetics (PK), and preliminary efficacy of ABT-165 when administered as monotherapy and in combination with paclitaxel or 5-fluoruracil, folinic acid and irinotecan (FOLFIRI) or ABBV-181 with/without paclitaxel in subjects with advanced solid tumors. Enrollment to Cohorts A, B were completed and for Cohorts C and D are recruiting.